Hologic Stock Outlook: Is Wall Street Bullish or Bearish?

Hologic, Inc. (HOLX), headquartered in Marlborough, Massachusetts, develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment. Valued at $19 billion by market cap, the company's core business units focus on diagnostics, breast health, GYN surgical, and skeletal health.

Shares of this medical technology company have underperformed the broader market considerably over the past year. HOLX has gained 11.2% over this time frame, while the broader S&P 500 Index ($SPX) has rallied nearly 28.3%. In 2024 alone, HOLX’s stock rose 13.9%, compared to SPX’s 17.6% rise on a YTD basis.